Hemoglobin combined with triglyceride and ferritin in predicting non-alcoholic fatty liver

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 7, 2014, Pages 1508-1514

  Jiang, Youzhao ^a   Zeng, Jun ^a   Chen, Bing ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hematocrit; Hemoglobin; Insulin resistance; Non alcoholic fatty liver disease; Red blood cells

Indexed keywords

FERRITIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIGESTIVE TRACT PARAMETERS; ERYTHROCYTE; FATTY LIVER INDEX; FEMALE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; ERYTHROCYTE COUNT; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; STATISTICAL MODEL;

ADULT; BIOLOGICAL MARKERS; ERYTHROCYTE COUNT; FEMALE; FERRITINS; HEMATOCRIT; HEMOGLOBINS; HUMANS; INSULIN; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PREDICTIVE VALUE OF TESTS; TRIGLYCERIDES;

EID: 84904281268     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12580     Document Type: Article

References (25)

1. Fan JG, Li F, Cai XB etal. The importance of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers. J. Gastroenterol. Hepatol. 2007; 22: 663-668.
2. Sookoian S, Rosselli MS, Gemma C etal. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter. Hepatology 2010; 52: 1992-2000.
3. Fan JG, Li F, Cai XB etal. Effects of nonalcoholic fatty liver disease on the development of metabolic disorders. J. Gastroenterol. Hepatol. 2007; 22: 1086-1091.
4. Adams LA, Lymp JF, St Sauver J etal. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129: 113-121.
5. Barbieri M, Ragno E, Benvenuti E etal. New aspects of insulin resistance syndrome: impact on haematological parameters. Diabetologia 2001; 44: 1232-1237.
6. Fan X, Liu EY, Freudenreich O etal. Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia. Schizophr. Res. 2010; 118: 211-217.
7. Phillips AC, Carroll D, Gale CR etal. Lymphocyte sub-population cell counts are associated with the metabolic syndrome and its components in the Vietnam Experience Study. Atherosclerosis 2010; 213: 294-298.
8. Lee YJ, Lee HR, Shim JY etal. Relationship between white blood cell count and nonalcoholic fatty liver disease. Dig. Liver Dis. 2010; 42: 888-894.
9. Bedogni G, Bellentani S, Miglioli L etal. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006; 6: 33.
10. Wallace TM, Levy JC, Mattews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-1495.
11. Farrell GC, Chitturi S, Lau GK etal.; Asia-Pacific Working Party on NAFLD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J. Gastroenterol. Hepatol. 2007; 22: 775-777.
12. Hanley AJ, Retnakaran R, Qi Y etal. Association of hematological parameters with insulin resistance and beta-cell dysfunction in nondiabetic subjects. J. Clin. Endocrinol. Metab. 2009; 94: 3824-3832.
13. Moan A, Nordby G, Os I etal. Relationship between hemorrheologic factors and insulin sensitivity in healthy young men. Metabolism 1994; 43: 423-427.
14. Bersch N, Groopman JE, Golde DW. Natural and synthetic insulin stimulates the growth of human erythroid progenitors in vitro. JCEM 1982; 55: 1209-1211.
15. Catalano C, Muscelli E, Natali A etal. Reciprocal association between insulin sensitivity and the haematocrit in man. Eur. J. Clin. Invest. 1997; 27: 634-637.
16. Fernández-Real JM, Peñarroja G, Castro A etal. Blood letting in highferritin type 2 diabetes: effect on insulin sensitivity and beta-cell function. Diabetes 2002; 51: 1000-1004.
17. Luque-Ramírez M, Alvarez-Blasco F, Botella-Carretero JI etal. Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses. Diabetes Care 2007; 30: 2309-2313.
18. Wong VW, Hui AY, Tsang SW etal. Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 2006; 4: 1154-1161.
19. Park SH, Kim BI, Yun JW etal. Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. J. Gastroenterol. Hepatol. 2004; 19: 694-698.
20. Sumida Y, Yoshikawa T, Okanoue T. Role of hepatic iron in non-alcoholic steatohepatitis. Hepatol. Res. 2009; 39: 213-222.
21. Julian CG, Vargas E, Gonzales M etal. Sleep-disordered breathing and oxidative stress in preclinical chronic mountain sickness (excessive erythrocytosis). Respir. Physiol. Neurobiol. 2013; 186: 188-196.
22. Jefferson JA, Simoni J, Escudero E etal. Increased oxidative stress following acute and chronic high altitude exposure. High Alt. Med. Biol. 2004; 5: 61-69.
23. Sonmez M, Saglam F, Karahan SC etal. Treatment related changes in antifibrinolytic activity in patients with polycythemia vera. Hematology 2010; 15: 391-396.
24. Winnicki M, Shamsuzzaman A, Lanfranchi P etal. Erythropoietin and obstructive sleep apnea. Am. J. Hypertens. 2004; 17: 783-786.
25. Choi JB, Loredo JS, Norman D etal. Does obstructive sleep apnea increase hematocrit? Sleep Breath. 2006; 10: 155-160.